Variant report
Variant | esv19613 |
---|---|
Chromosome Location | chr3:60025-63479 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:6)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:6 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr3:62164-62476 | IMR90 | lung: | n/a | n/a |
2 | CTCF | chr3:60675-60771 | GM10248 | blood: | n/a | n/a |
3 | MAFK | chr3:61436-61646 | HepG2 | liver: | n/a | chr3:61521-61532 chr3:61522-61533 chr3:61517-61533 chr3:61520-61534 chr3:61522-61533 chr3:61521-61532 |
4 | MAFK | chr3:63386-63425 | HepG2 | liver: | n/a | n/a |
5 | POLR2A | chr3:62116-62393 | SK-N-SH | brain: | n/a | n/a |
6 | TCF12 | chr3:62091-62571 | SK-N-SH | brain: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000223587 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183190499 | chr3:60676-60677 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs376763689 | chr3:60686-60687 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs188073721 | chr3:60687-60688 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs192023809 | chr3:60688-60689 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs143697718 | chr3:60759-60760 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs531816158 | chr3:60768-60769 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs13081384 | chr3:61466-61467 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs13060385 | chr3:61495-61496 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs541152469 | chr3:61553-61554 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs559726984 | chr3:61589-61590 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs13067440 | chr3:61591-61592 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs145505212 | chr3:61642-61643 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs184742076 | chr3:61657-61658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs73009205 | chr3:61662-61663 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs139163391 | chr3:61694-61695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs368368123 | chr3:61702-61703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs13067752 | chr3:61705-61706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs374428640 | chr3:61710-61711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs189600515 | chr3:61711-61712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs144053997 | chr3:61733-61734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs369665104 | chr3:61748-61749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs62240674 | chr3:61762-61763 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs367643930 | chr3:62113-62114 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs556974490 | chr3:62120-62121 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs143391690 | chr3:62168-62169 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs187331111 | chr3:62179-62180 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs539425352 | chr3:62214-62215 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs528665990 | chr3:62219-62220 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs9799162 | chr3:62226-62227 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs568016892 | chr3:62232-62233 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs190928083 | chr3:62236-62237 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs550559966 | chr3:62254-62255 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs535291411 | chr3:62266-62267 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs9681823 | chr3:62309-62310 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs151333018 | chr3:62324-62325 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs558082390 | chr3:62328-62329 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs180933565 | chr3:62337-62338 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs73009208 | chr3:62425-62426 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs9682412 | chr3:62437-62438 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs533112258 | chr3:62464-62465 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs186343931 | chr3:62481-62482 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs190261893 | chr3:62508-62509 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs140541705 | chr3:62521-62522 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs566612695 | chr3:62537-62538 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs534081286 | chr3:62546-62547 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs375808044 | chr3:62603-62604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs9799274 | chr3:62614-62615 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs369716732 | chr3:62680-62681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs150446262 | chr3:62689-62690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs540443415 | chr3:62696-62697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Lung cancer | 16618734 | CNVD |
Autism | 18349135 | CNVD |
Breast cancer | 20409316 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Intellectual disability | 22045946 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Mental retardation | 17124404 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20967226 | CNVD |
Autism | 22543975 | CNVD |
Attention deficit hyperactivity disorder | 19546859 | CNVD |
Ependymoma | 20639864 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:61600-61800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr3:62200-62800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr3:62400-62800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |